Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I)

Department of Medicine, University of South Carolina, Columbia, USA.

OBJECTIVES. In-hospital peripheral vascular complications of balloon angioplasty were compared with those of directional atherectomy in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) to identify patients at risk and evaluate costs and outcomes. BACKGROUND. The incidence, costs and outcomes of peripheral vascular complications after coronary intervention have not been fully characterized as a function of randomly assigned therapy. METHODS. At 35 sites in the United States and Europe, 1,012 patients were randomized. Peripheral vascular complications were defined as the composite of pulse loss, pseudoaneurysm, hematoma > 4 cm in diameter or groin hemorrhage necessitating blood transfusion. Logistic models were derived to 1) predict these complications from baseline and procedural characteristics, 2) test the relevance of randomization assignment, and 3) assess their impact on hospital costs and long-term outcomes. RESULTS. Sixty-seven patients (6.6%) developed peripheral vascular complications, of whom 15 (22.4%) required a blood transfusion, 14 (20.9%) underwent vascular surgery, and 2 (3.0%) died. Both in-hospital deaths occurred in patients with peripheral vascular complications. There was no difference in composite peripheral vascular complication rates among patients randomized to angioplasty or atherectomy. Greater age, female gender, postprocedural heparin and intraaortic balloon counterpulsation were predictive of increased risk. In a representative 60% subset, mean hospital costs increased from $9,583 in patients without to $18,350 in those with peripheral vascular complications (p = 0.0001). The unadjusted mortality rate at 1 year was 7.5% for patients with peripheral vascular complications compared with 1.1% for all others (p = 0.0001). These complications identified patients at greater risk of death, myocardial infarction or repeat revascularization at 30 days and 1 year. The atherectomy group had a trend toward more frequent deaths and myocardial infarction. CONCLUSIONS. Directional atherectomy and balloon angioplasty had similar in-hospital peripheral vascular complication rates. Female gender, greater age, postprocedural heparin and intraaortic balloon counterpulsation were predictive of higher risk. The twofold increase in cost and sevenfold increase in long-term deaths highlight the need to prevent these periprocedural events and monitor patients closely.

This article has been cited by other articles:

				S. B. Joshi, D. D. Mendoza, D. H. Steinberg, M. A. Goldstein, C. F. Lopez, A. Raizon, G. Weissman, L. F. Satler, A. D. Pichard, and Wm. G. Weigold Ultra-Low-Dose Intra-Arterial Contrast Injection for Iliofemoral Computed Tomographic Angiography J. Am. Coll. Cardiol. Img., December 1, 2009; 2(12): 1404 - 1411. [Abstract] [Full Text] [PDF]

				P. M. Grossman, H. S. Gurm, R. McNamara, T. LaLonde, H. Changezi, D. Share, D. E. Smith, S. J. Chetcuti, M. Moscucci, and for the Blue Cross Blue Shield of Michigan Cardiov Percutaneous Coronary Intervention Complications and Guide Catheter Size: Bigger Is Not Better J. Am. Coll. Cardiol. Intv., July 1, 2009; 2(7): 636 - 644. [Abstract] [Full Text] [PDF]

				M.-A. Ohlow, M.-A. Secknus, H. von Korn, R. Weiss, and B. Lauer Percutaneous Thrombin Injection for Treatment of Iatrogenic Femoral Artery Pseudoaneurysms: A Case for Caution Angiology, July 1, 2008; 59(3): 372 - 375. [Abstract] [PDF]

				A. Kadner, J. Schmidli, I. Schwegler, F. Dick, F. Schonhoff, T. Carrel, and H. Savolainen Complications Associated With the Arterial Puncture Closure Device--Angio-Seal Vascular and Endovascular Surgery, June 1, 2008; 42(3): 225 - 227. [Abstract] [PDF]

				J. M. Wilson and J. T. Willerson Myocardial Revascularization with Percutaneous Devices Card. Surg. Adult, January 1, 2008; 3(2008): 573 - 598. [Full Text]

				K. Khaghany, F. Al-Ali, T. Spigelmoyer, R. Pimentel, and K. Wharton Efficacy and Safety of the Perclose Closer S Device After Neurointerventional Procedures: Prospective Study and Literature Review AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1420 - 1424. [Abstract] [Full Text] [PDF]

				A. J. Lansky, J. S. Hochman, P. A. Ward, G. S. Mintz, R. Fabunmi, P. B. Berger, G. New, C. L. Grines, C. G. Pietras, M. J. Kern, et al. Percutaneous Coronary Intervention and Adjunctive Pharmacotherapy in Women: A Statement for Healthcare Professionals From the American Heart Association Circulation, February 22, 2005; 111(7): 940 - 953. [Abstract] [Full Text] [PDF]

				M. Koreny, E. Riedmuller, M. Nikfardjam, P. Siostrzonek, and M. Mullner Arterial Puncture Closing Devices Compared With Standard Manual Compression After Cardiac Catheterization: Systematic Review and Meta-analysis JAMA, January 21, 2004; 291(3): 350 - 357. [Abstract] [Full Text] [PDF]

				R. J. Applegate, M. A. Grabarczyk, W. C. Little, T. Craven, M. Walkup, F. R. Kahl, G. A. Braden, K. M. Rankin, and M. A. Kutcher Vascular closure devices in patients treated with anticoagulation and iib/iiia receptor inhibitors during percutaneous revascularization J. Am. Coll. Cardiol., July 3, 2002; 40(1): 78 - 83. [Abstract] [Full Text] [PDF]

				K T Koch, J J Piek, R J de Winter, K Mulder, C E Schotborgh, J G P Tijssen, and K I Lie Two hour ambulation after coronary angioplasty and stenting with 6 F guiding catheters and low dose heparin Heart, January 1, 1999; 81(1): 53 - 56. [Abstract] [Full Text]